Classification
- Anatomical main groupAAlimentary tract and metabolism
- Therapeutic subgroupA16
- Pharmacological subgroupA16A
- Chemical subgroupA16AXVarious alimentary tract and metabolism products
- Chemical substanceA16AX04Nitisinone
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 12 registrations
- MDK-Nitisinone2 MG · Capsule · Mendelikabs INC
- MDK-Nitisinone5 MG · Capsule · Mendelikabs INC
- MDK-Nitisinone10 MG · Capsule · Mendelikabs INC
- Orfadin2 MG · Capsule · Swedish Orphan Biovitrum AB (Publ)
Spain
AEMPS · 12 registrations
At a glance
- ATC code
- A16AX04
- ATC group
- Alimentary tract and metabolism
- Registers
- 8
- Historical lists
- 3
- Registrations
- 66
- With their own page
- 46
- Companies
- 19
All medicines with Nitisinone
Human medicines from every register that match Nitisinone by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
66 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Nitisinone | United States | 10MG, 20MG, 2MG … | capsule | Marketed | Eton |
| Nitisinone MDK 2 MG Capsulas Duras | Spain | 2 mg | cápsula dura | Marketed | Mendelikabs Europe Limited |
| Nitisinone MDK 5 MG Capsulas Duras | Spain | 5 mg | cápsula dura | Marketed | Mendelikabs Europe Limited |
| Nitisinone MDK 10 MG Capsulas Duras | Spain | 10 mg | cápsula dura | Marketed | Mendelikabs Europe Limited |
| Nitisinone Dipharma 2 mg, harde capsules | Netherlands | Capsule, hard | Authorised | Dipharma Arzneimittel GmbH | |
| Nitisinone Dipharma 5 mg, harde capsules | Netherlands | Capsule, hard | Authorised | Dipharma Arzneimittel GmbH | |
| Nitisinone Dipharma 10 mg, harde capsules | Netherlands | Capsule, hard | Authorised | Dipharma Arzneimittel GmbH | |
| Nitisinone Dipharma 20 mg, harde capsules | Netherlands | Capsule, hard | Authorised | Dipharma Arzneimittel GmbH | |
| Nitisinone LogixX Pharma | New Zealand | Cap 2 mg | Funded | ||
| Nitisinone LogixX Pharma | New Zealand | Cap 10 mg | Funded | ||
| Nitisinone LogixX Pharma | New Zealand | Cap 5 mg | Funded | ||
| MDK-Nitisinone | Canada | 2 MG | Capsule | Marketed | Mendelikabs INC |
| MDK-Nitisinone | Canada | 5 MG | Capsule | Marketed | Mendelikabs INC |
| MDK-Nitisinone | Canada | 10 MG | Capsule | Marketed | Mendelikabs INC |
| MDK-Nitisinone | Canada | 20 MG | Capsule | Not marketed | Mendelikabs INC |
| Nityr | United States | 10MG, 2MG, 5MG | tablet | Marketed | Cycle |
| Harliku | United States | 2MG | tablet | Marketed | Cycle |
| Orfadin | United States | 4MG/ML | suspension | Marketed | Swedish Orphan |
| Orfadin | United States | 10MG, 20MG, 2MG … | capsule | Marketed | Swedish Orphan |
| Nityr | European Union | Authorised | Cycle Pharmaceuticals (Europe) Ltd | ||
| Nitisinona Dipharma 2 MG Capsulas Duras Efg | Spain | 2 mg | cápsula dura | Marketed | Dipharma Arzneimittel Gmbh |
| Nitisinona Dipharma 5 MG Capsulas Duras Efg | Spain | 5 mg | cápsula dura | Marketed | Dipharma Arzneimittel Gmbh |
| Nitisinona Dipharma 10 MG Capsulas Duras Efg | Spain | 10 mg | cápsula dura | Marketed | Dipharma Arzneimittel Gmbh |
| Nitisinona Dipharma 20 MG Capsulas Duras Efg | Spain | 20 mg | cápsula dura | Marketed | Dipharma Arzneimittel Gmbh |
| Nitikabs | Brazil | Authorised | Pharmedic Pharmaceuticals, Importacao, Exportacao, Distribuicao, Comercio e Representacoes Ltda |